Report Detail
Global Pamiparib Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4706187 |
- 09 June, 2026 |
- Global |
- 70 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Pamiparib market size was valued at US$ 123 million in 2025 and is forecast to a readjusted size of US$ 422 million by 2032 with a CAGR of 10.9% during review period.
In 2025, global Pamiparib production reached approximately 350,000 units.Pamiparib is an oral small-molecule targeted therapy that belongs to the class of Poly(ADP-ribose) polymerase (PARP) inhibitors. It is mainly used to treat tumors with homologous recombination repair deficiencies, such as those with BRCA mutation, including ovarian cancer and breast cancer. It works by inhibiting the activity of PARP enzymes, thereby blocking the repair of DNA damage in cancer cells and ultimately inducing tumor cell death. Pamiparib also has good penetration across the blood–brain barrier, showing potential therapeutic value in tumors with central nervous system metastases.
Pamiparib, as one of the domestically developed innovative PARP inhibitors, is positioned within the rapidly growing targeted anti-cancer drug market. Driven by the increasing adoption of BRCA mutation testing, the advancement of precision medicine, and the rising incidence of cancer, the overall PARP inhibitor market continues to expand. In the Chinese market, Pamiparib holds certain competitive advantages due to its local R&D background, particularly in pricing, reimbursement access, and clinical availability. In addition, its strong ability to penetrate the blood–brain barrier provides a point of differentiation. Currently, the drug is still in the stage of market introduction and volume expansion. Future growth will mainly depend on the expansion of indications (such as breast cancer and ovarian cancer), combination therapy strategies, and international market development. However, it also faces challenges such as intensified competition from other PARP inhibitors and pressure from healthcare cost control policies.
This report is a detailed and comprehensive analysis for global Pamiparib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Pamiparib market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Pamiparib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Pamiparib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global Pamiparib market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pamiparib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pamiparib market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BeiGene, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Pamiparib market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
20 mg/vial
50 mg/vial
Market segment by Combined Medication
Pamiparib + Tislelizumab
Pamiparib + Anlotinib
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Application
Advanced Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Primary Peritoneal Carcinoma (PPC)
Endometrial Cancer
Prostate Cancer
Pancreatic Cancer
Others
Major players covered
BeiGene
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pamiparib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pamiparib, with price, sales quantity, revenue, and global market share of Pamiparib from 2021 to 2026.
Chapter 3, the Pamiparib competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pamiparib breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pamiparib market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pamiparib.
Chapter 14 and 15, to describe Pamiparib sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pamiparib Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 20 mg/vial
- 1.3.3 50 mg/vial
- 1.4 Market Analysis by Combined Medication
- 1.4.1 Overview: Global Pamiparib Consumption Value by Combined Medication: 2021 Versus 2025 Versus 2032
- 1.4.2 Pamiparib + Tislelizumab
- 1.4.3 Pamiparib + Anlotinib
- 1.5 Market Analysis by Sales Channels
- 1.5.1 Overview: Global Pamiparib Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
- 1.5.2 Hospital
- 1.5.3 Retail
- 1.5.4 Online
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Pamiparib Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Advanced Ovarian Cancer
- 1.6.3 Fallopian Tube Cancer
- 1.6.4 Primary Peritoneal Cancer
- 1.6.5 Primary Peritoneal Carcinoma (PPC)
- 1.6.6 Endometrial Cancer
- 1.6.7 Prostate Cancer
- 1.6.8 Pancreatic Cancer
- 1.6.9 Others
- 1.7 Global Pamiparib Market Size & Forecast
- 1.7.1 Global Pamiparib Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Pamiparib Sales Quantity (2021-2032)
- 1.7.3 Global Pamiparib Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 BeiGene
- 2.1.1 BeiGene Details
- 2.1.2 BeiGene Major Business
- 2.1.3 BeiGene Pamiparib Product and Services
- 2.1.4 BeiGene Pamiparib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 BeiGene Recent Developments/Updates
3 Competitive Environment: Pamiparib by Manufacturer
- 3.1 Global Pamiparib Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Pamiparib Revenue by Manufacturer (2021-2026)
- 3.3 Global Pamiparib Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Pamiparib by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Pamiparib Manufacturer Market Share in 2025
- 3.4.3 Top 6 Pamiparib Manufacturer Market Share in 2025
- 3.5 Pamiparib Market: Overall Company Footprint Analysis
- 3.5.1 Pamiparib Market: Region Footprint
- 3.5.2 Pamiparib Market: Company Product Type Footprint
- 3.5.3 Pamiparib Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Pamiparib Market Size by Region
- 4.1.1 Global Pamiparib Sales Quantity by Region (2021-2032)
- 4.1.2 Global Pamiparib Consumption Value by Region (2021-2032)
- 4.1.3 Global Pamiparib Average Price by Region (2021-2032)
- 4.2 North America Pamiparib Consumption Value (2021-2032)
- 4.3 Europe Pamiparib Consumption Value (2021-2032)
- 4.4 Asia-Pacific Pamiparib Consumption Value (2021-2032)
- 4.5 South America Pamiparib Consumption Value (2021-2032)
- 4.6 Middle East & Africa Pamiparib Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Pamiparib Sales Quantity by Type (2021-2032)
- 5.2 Global Pamiparib Consumption Value by Type (2021-2032)
- 5.3 Global Pamiparib Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Pamiparib Sales Quantity by Application (2021-2032)
- 6.2 Global Pamiparib Consumption Value by Application (2021-2032)
- 6.3 Global Pamiparib Average Price by Application (2021-2032)
7 North America
- 7.1 North America Pamiparib Sales Quantity by Type (2021-2032)
- 7.2 North America Pamiparib Sales Quantity by Application (2021-2032)
- 7.3 North America Pamiparib Market Size by Country
- 7.3.1 North America Pamiparib Sales Quantity by Country (2021-2032)
- 7.3.2 North America Pamiparib Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Pamiparib Sales Quantity by Type (2021-2032)
- 8.2 Europe Pamiparib Sales Quantity by Application (2021-2032)
- 8.3 Europe Pamiparib Market Size by Country
- 8.3.1 Europe Pamiparib Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Pamiparib Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Pamiparib Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Pamiparib Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Pamiparib Market Size by Region
- 9.3.1 Asia-Pacific Pamiparib Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Pamiparib Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Pamiparib Sales Quantity by Type (2021-2032)
- 10.2 South America Pamiparib Sales Quantity by Application (2021-2032)
- 10.3 South America Pamiparib Market Size by Country
- 10.3.1 South America Pamiparib Sales Quantity by Country (2021-2032)
- 10.3.2 South America Pamiparib Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Pamiparib Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Pamiparib Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Pamiparib Market Size by Country
- 11.3.1 Middle East & Africa Pamiparib Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Pamiparib Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Pamiparib Market Drivers
- 12.2 Pamiparib Market Restraints
- 12.3 Pamiparib Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Pamiparib and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Pamiparib
- 13.3 Pamiparib Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Pamiparib Typical Distributors
- 14.3 Pamiparib Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pamiparib. Industry analysis & Market Report on Pamiparib is a syndicated market report, published as Global Pamiparib Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Pamiparib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
